Development of a Clinical Prediction Model for Ultra-Early Mild Acute Ischemic Stroke: A Comprehensive Review and Future Directions
Introduction:
Cerebrovascular disease, particularly Acute Ischemic Stroke (AIS), remains a significant health concern in China. Early diagnosis and treatment are crucial for improving patient outcomes. This study aims to develop a clinical prediction model for distinguishing between CT-negative mild AIS and Transient Ischemic Attack (TIA) using readily available serum biomarkers and NIHSS scores.
Key Findings and Novel Contributions:
- The model integrates NIHSS scores with serum biomarkers like CRP, glucose, cholesterol, triglycerides, and LDL, offering a practical tool for resource-limited settings.
- Multivariate analysis identified NIHSS, CRP, glucose, cholesterol, triglycerides, and LDL as independent predictors of mild AIS.
- The model demonstrated strong discriminative ability with AUC values of 0.830 in the training set and 0.804 in the validation set.
- It showed good calibration and clinical utility, making it a valuable resource for early diagnosis and treatment.
Controversial Points and Future Directions:
- The study's single-center nature and small sample size may limit generalizability. Further multi-center studies with larger cohorts are needed.
- Emerging biomarkers like GFAP and S100B could be incorporated for improved accuracy.
- Artificial intelligence-based integration of clinical, laboratory, and imaging data warrants exploration.
Conclusion:
This prediction model provides a practical tool for identifying CT-negative ultra-early mild AIS in resource-limited settings. Future studies should validate the model and assess its impact on clinical decision-making and healthcare resource utilization.
